Law360, New York (March 07, 2012, 5:52 PM ET) -- Pfizer Inc., GlaxoSmithKline PLC and six other major drugmakers were sued in class actions under federal racketeering and antitrust laws Wednesday for allegedly subsidizing illegal copayments for brand-name prescription drugs such as Lipitor and Nexium through the promotion of copay coupons.
A coalition of health plans allege that Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Co., GSK, Merck & Co. Inc., Novartis AG and Pfizer are paying undisclosed kickbacks to privately-insured individuals so that they choose the companies' brand-name drugs instead of less expensive alternatives....
Pfizer, Others Sued By Health Plans Over Copay Coupons
To view the full article, take a free trial now.
